VERTEX PHARMACEUTICALS INC / MA Restricted Cash and Cash Equivalents, Noncurrent
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Restricted Cash and Cash Equivalents, Noncurrent of $3.35 million as of 2019-12-31, per its 10-K filed 2020-02-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2020-02-13
- 2019-12-31: Restricted Cash and Cash Equivalents, Noncurrent $3.35M.
- 2018-12-31: Restricted Cash and Cash Equivalents, Noncurrent $3.21M.
- 2017-12-31: Restricted Cash and Cash Equivalents, Noncurrent $0.00.
- 2016-12-31: Restricted Cash and Cash Equivalents, Noncurrent $0.00; Restricted Cash and Cash Equivalents, Noncurrent as first filed $52.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent | Restricted Cash and Cash Equivalents, Noncurrent as first filed |
|---|---|---|
| 2019-12-31 | $3.35M 10-K · filed 2020-02-13 | |
| 2018-12-31 | $3.21M 10-K · filed 2020-02-13 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-13 | |
| 2016-12-31 | $0.00 10-K · filed 2020-02-13 | $52.00K 10-K · filed 2017-02-23 |
| 2016-09-30 | $22.09M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $22.09M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $22.09M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $22.08M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $22.09M 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $22.15M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $22.14M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $176.00K 10-K · filed 2016-02-16 | |
| 2014-09-30 | $121.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $129.00K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $130.00K 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $130.00K 10-Q · filed 2014-11-06 | |
| 2013-09-30 | $127.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $122.00K 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $31.93M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $31.93M 10-K · filed 2014-02-11 | |
| 2012-09-30 | $32.17M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $34.09M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $34.09M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $34.09M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $34.12M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $34.11M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $34.11M 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $34.09M 10-K · filed 2012-02-22 | |
| 2010-09-30 | $34.09M 10-Q · filed 2010-10-28 | |
| 2010-06-30 | $34.09M 10-Q · filed 2010-08-03 | |
| 2010-03-31 | $30.31M 10-Q · filed 2010-05-03 | |
| 2009-12-31 | $30.31M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |